New investment dealing with temperature reduction in patients
The company shall develop a therapeutic agent for temperature reduction in cardiac arrest and stroke patients. Temperature reduction in patients suffering from ischemia has proven efficient in reducing brain damage. Cooling is routinely used in patients suffering from cardiac arrest, but there is presently no approved way of cooling stroke patients.
Click here to read the full press release